» Articles » PMID: 38892858

Integrative Assessment of Seminal Plasma Biomarkers: A Narrative Review Bridging the Gap Between Infertility Research and Clinical Practice

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Jun 19
PMID 38892858
Authors
Affiliations
Soon will be listed here.
Abstract

Infertility represents a significant global health challenge impacting millions of couples worldwide. Approximately half of all infertile couples exhibit compromised semen quality, indicative of diminished male fertility. While the diagnosis of male infertility traditionally relies on semen analysis, its limitations in providing a comprehensive assessment of male reproductive health have spurred efforts to identify novel biomarkers. Seminal plasma, a complex fluid containing proteins, lipids, and metabolites, has emerged as a rich source of such indicators. Reproduction depends heavily on seminal plasma, the primary transporter of chemicals from male reproductive glands. It provides a non-invasive sample for urogenital diagnostics and has demonstrated potential in the identification of biomarkers linked to illnesses of the male reproductive system. The abundance of seminal proteins has enabled a deeper understanding of their biological functions, origins, and differential expression in various conditions associated with male infertility, including azoospermia, asthenozoospermia, oligozoospermia, teratozoospermia, among others. The true prevalence of male infertility is understated due to the limitations of the current diagnostic techniques. This review critically evaluates the current landscape of seminal plasma biomarkers and their utility in assessing male infertility. Βy bridging the gap between research and clinical practice, the integrative assessment of seminal plasma biomarkers offers a multimodal approach to comprehensively evaluate male infertility.

Citing Articles

Association Between Zinc Levels and the Impact of Its Deficiency on Idiopathic Male Infertility: An Up-to-Date Review.

Zecevic N, Veselinovic A, Perovic M, Stojsavljevic A Antioxidants (Basel). 2025; 14(2).

PMID: 40002352 PMC: 11851646. DOI: 10.3390/antiox14020165.


Comparative Analysis of Fluorescence In Situ Hybridization and Next-Generation Sequencing in Sperm Evaluation: Implications for Preimplantation Genetic Testing and Male Infertility.

Moustakli E, Gkountis A, Dafopoulos S, Zikopoulos A, Sotiriou S, Zachariou A Int J Mol Sci. 2024; 25(20).

PMID: 39457078 PMC: 11508275. DOI: 10.3390/ijms252011296.

References
1.
van den Berg J, Molina N, Altmae S, Arends B, Steba G . A systematic review identifying seminal plasma biomarkers and their predictive ability on IVF and ICSI outcomes. Reprod Biomed Online. 2023; 48(2):103622. DOI: 10.1016/j.rbmo.2023.103622. View

2.
Koistinen H, Koistinen R, Hyden-Granskog C, MAGNUS O, Seppala M . Seminal plasma glycodelin and fertilization in vitro. J Androl. 2000; 21(5):636-40. View

3.
Ahmad A, Imran M, Ahsan H . Biomarkers as Biomedical Bioindicators: Approaches and Techniques for the Detection, Analysis, and Validation of Novel Biomarkers of Diseases. Pharmaceutics. 2023; 15(6). PMC: 10303887. DOI: 10.3390/pharmaceutics15061630. View

4.
Barratt C, Bjorndahl L, De Jonge C, Lamb D, Osorio Martini F, McLachlan R . The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities. Hum Reprod Update. 2017; 23(6):660-680. PMC: 5850791. DOI: 10.1093/humupd/dmx021. View

5.
Finocchi F, Pelloni M, Balercia G, Pallotti F, Radicioni A, Lenzi A . Seminal plasma miRNAs in Klinefelter syndrome and in obstructive and non-obstructive azoospermia. Mol Biol Rep. 2020; 47(6):4373-4382. DOI: 10.1007/s11033-020-05552-x. View